Trade Summary

3 days ago, Barnes Alane P, serving as GC at Biocryst Pharmaceuticals Inc (BCRX), sold 62,500 shares at $9.54 per share, for a total transaction value of $596,250.00. Following this transaction, Barnes Alane P now holds 400,703 shares of BCRX.

This sale represents a 13.00% decrease in Barnes Alane P's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, May 13, 2026 and publicly disclosed via SEC Form 4 filing on Friday, May 15, 2026 at 4:08 PM ET, 2 days after the trade was made.

Biocryst Pharmaceuticals Inc operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.